Resources|Podcasts|March 28, 2025
Transformations in Drug Development for Cell and Gene Therapies
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Related Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
Tom Sellig on CDMO Innovation and US Manufacturing Growth
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
5